leadf
logo-loader
view360Medlink

360Medlink 'well positioned' to understand compliance needs from pharma companies

360Medlink President J. Manassé Theagene sat down with Proactive at the BIO Investor Forum in San Francisco. 

The privately-held software development company is focused on bringing digital health solutions to pharmaceutical and biotech companies, government agencies and healthcare organizations.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Algernon Pharmaceuticals enrolls final patient in Phase 2b/3 human study of...

Algernon Pharmaceuticals (CSE: AGN- OTCQB: AGNPF) CEO Christopher Moreau joined Steve Darling from Proactive to bring news the company has enrolled their final patient multinational Phase 2b/3 human study of Ifenprodil for the treatment of COVID-19. Moreau telling Proactive the aggregate...

1 hour, 2 minutes ago

2 min read